DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Kaufman HL, Andtbacka RHI, Collichio FA. et al.
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials.

Journal for immunotherapy of cancer 2017;
5: 72

Download Bibliographical Data

Access:
Access: